Back to search

Mucosal immunity to infection with implications for vaccine development

Data up to Jan 2025

Published1994
Citations176
References67

Total Citations Per Year

Abstract

References (67)

TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional Properties

1989 • 7,558 citations

Direct Gene Transfer into Mouse Muscle in Vivo

1990 • 3,985 citations

Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein

1993 • 2,330 citations

New use of BCG for recombinant vaccines

1991 • 1,463 citations

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations.

1993 • 1,122 citations

Immunoglobulin A (IgA): Molecular and Cellular Interactions Involved in IgA Biosynthesis and Immune Response

1987 • 956 citations

The mucosal immune system: from fundamental concepts to vaccine development

1992 • 912 citations

Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin

1992 • 810 citations

Expression of hepatitis B surface antigen in transgenic plants.

1992 • 711 citations

Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches

1990 • 691 citations

Selection of Bacterial Virulence Genes That Are Specifically Induced in Host Tissues

1993 • 671 citations

Nonreplicating vaccinia vector efficiently expresses recombinant genes.

1992 • 598 citations

Immunological adjuvants: a role for liposomes

1990 • 468 citations

Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues.

1993 • 457 citations

Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic

1987 • 434 citations

Systemic tolerance and secretory immunity after oral immunization.

1980 • 432 citations

Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin.

1992 • 369 citations

Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium

1992 • 343 citations

Passive transfer of local immunity to influenza virus infection by IgA antibody.

1991 • 322 citations

Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccines

1991 • 315 citations

Role of Cytokines in the Differentiation of CD4+ T‐Cell Subsets in vivo

1991 • 289 citations

Distribution of Poliovirus Antibody in Serum, Nasopharynx and Alimentary Tract Following Segmental Immunization of Lower Alimentary Tract with Poliovaccine

1969 • 272 citations

Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.

1993 • 269 citations

Protection Against Vaginal SIV Transmission with Microencapsulated Vaccine

1993 • 265 citations

New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection

1991 • 257 citations

Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues

1989 • 252 citations

Immunology of breast milk.

1979 • 249 citations

Use of the nirB Promoter to Direct the Stable Expression of Heterologous Antigens in Salmonella Oral Vaccine Strains: Development of a Single–Dose Oral Tetanus Vaccine

1992 • 233 citations

Immunoglobulin A mediation of murine nasal anti-influenza virus immunity

1991 • 229 citations

Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant

1993 • 208 citations

Expression of rotavirus VP2 produces empty corelike particles

1991 • 199 citations

Mechanism of action of cholera toxin

1980 • 199 citations

A mouse T cell product that preferentially enhances IgA production. I. Biologic characterization.

1987 • 196 citations

Construction of genetically defined double aro mutants of Salmonella typhi

1991 • 191 citations

Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis.

1990 • 188 citations

Immune-stimulating complexes containing Quil A and protein antigen prime class I MHC-restricted T lymphocytes in vivo and are immunogenic by the oral route.

1991 • 174 citations

The expression of hybrid HIV:Ty virus-like particles in yeast

1987 • 163 citations

Novel Delivery Systems for Oral Vaccines

1994 • 155 citations

Induction of Mucosal and Systemic Immunity to a Recombinant Simian Immunodeficiency Viral Protein

1992 • 142 citations

Vaccine-Containing Biodegradable Microspheres Specifically Enter the Gut-Associated Lymphoid Tissue Following Oral Administration and Induce a Disseminated Mucosal Immune Response

1989 • 132 citations

Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination

1990 • 124 citations

Recombinant human respiratory syncytial virus (RSV)monoclonal antibody Fab is effective therapeutically when introduced directlyinto the lungs of RSV-infected mice.

1994 • 122 citations

The in vitro production of cytokines by mucosal lymphocytes immunized by oral administration of keyhole limpet hemocyanin using cholera toxin as an adjuvant

1991 • 120 citations

Oral vaccination of mice against tetanus by use of a live attenuated Salmonella carrier

1990 • 113 citations

T Lymphocytes in Genital Lymph Nodes Protect Mice from Intravaginal Infection with Herpes Simplex Virus Type 2

1989 • 93 citations

Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2

1990 • 92 citations

Safety and immunogenicity in North Americans of a single dose of live oral cholera vaccine CVD 103-HgR: results of a randomized, placebo-controlled, double-blind crossover trial

1992 • 90 citations

Construction of a genetically defined Salmonella typhi Ty2 aroA, aroC mutant for the engineering of a candidate oral typhoid-tetanus vaccine

1992 • 81 citations

Oral immunization with Toxoplasma gondii antigens in association with cholera toxin induces enhanced protective and cell-mediated immunity in C57BL/6 mice

1993 • 80 citations

Comparative effectiveness of the cholera toxin B subunit and alkaline phosphatase as carriers for oral vaccines

1993 • 79 citations

Hepatitis B virus nucleocapsid/pre-S2 fusion proteins expressed in attenuated Salmonella for oral vaccination.

1990 • 76 citations

Immunobiology of the Tonsils and Adenoids

2015 • 74 citations

Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children

1993 • 73 citations

Oral immunization with recombinant BCG induces cellular and humoral immune responses against the foreign antigen

1993 • 73 citations

The iscom structure as an immune-enhancing moiety: experience with viral systems

1992 • 72 citations

Cholera toxin B-subunit gene fusion: structural and functional analysis of the chimeric protein

1990 • 70 citations

Stabilization of recombinant avirulent vaccine strains in vivo

1990 • 68 citations

Immunogenicity of Recombinant Human Adenovirus-Human Immunodeficiency Virus Vaccines in Chimpanzees

1993 • 58 citations

Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 Gag and Pol proteins upon infection

1993 • 56 citations

Escherichia coli heat-labile toxin subunit B fusions with Streptococcus sobrinus antigens expressed by Salmonella typhimurium oral vaccine strains: importance of the linker for antigenicity and biological activities of the hybrid proteins

1993 • 49 citations

Characterization of poliovirus-specific T lymphocytes in the peripheral blood of Sabin-vaccinated humans

1993 • 39 citations

Amplification of the secretory IgA response toToxoplasma gondiiusing cholera toxin

1991 • 32 citations

Enhancement of systemic and mucosal immune responses following oral administration of liposomes

1993 • 28 citations

Efficacy of oral administration of live herpes simplex virus type 1 as a vaccine

1992 • 21 citations

Vaccines against enterotoxigenic bacterial pathogens based on hybrid salmonella that express heterologous antigens

1990 • 18 citations

Immunobiology of the Tonsils and Adenoids

1994 • 14 citations

Naked DNA and vaccine design

1993 • 6 citations

Cited By (0)

Loading...
Mucosal immunity to infection with implications for vaccine development (1994) – Current Opinion in Immunology | Metascience Observatory Explorer